These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15284847)

  • 1. Complex imprinting.
    Beaudet AL
    Nat Genet; 2004 Aug; 36(8):793-5. PubMed ID: 15284847
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutation analysis of GNAS1 and overlapping transcripts in Silver-Russell syndrome patients.
    Eggermann T; Meyer E; Schönherr N; Flick F; Chauvistré H; Mavany M; Wollmann HA
    Mol Genet Metab; 2007 Feb; 90(2):224-6. PubMed ID: 17056291
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pseudohypoparathyroidism].
    Yasuda T
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():352-6. PubMed ID: 16279661
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pseudopseudohypoparathyroidism and genomic imprinting].
    Minagawa M
    Clin Calcium; 2007 Aug; 17(8):1229-33. PubMed ID: 17660620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological dysfunctions associated with mutations of the imprinted Gnas locus.
    Krechowec S; Plagge A
    Physiology (Bethesda); 2008 Aug; 23():221-9. PubMed ID: 18697996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding.
    Plagge A; Gordon E; Dean W; Boiani R; Cinti S; Peters J; Kelsey G
    Nat Genet; 2004 Aug; 36(8):818-26. PubMed ID: 15273686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pseudohypoparathyroidism type I b and genomic imprinting].
    Fukumoto S
    Clin Calcium; 2007 Aug; 17(8):1222-7. PubMed ID: 17660619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cis-acting control region is required exclusively for the tissue-specific imprinting of Gnas.
    Williamson CM; Ball ST; Nottingham WT; Skinner JA; Plagge A; Turner MD; Powles N; Hough T; Papworth D; Fraser WD; Maconochie M; Peters J
    Nat Genet; 2004 Aug; 36(8):894-9. PubMed ID: 15273687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB.
    Liu J; Nealon JG; Weinstein LS
    Hum Mol Genet; 2005 Jan; 14(1):95-102. PubMed ID: 15537666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the Gs alpha gene causing hormone resistance.
    Mantovani G; Spada A
    Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):501-13. PubMed ID: 17161328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variation of the extra-large stimulatory G protein alpha-subunit leads to Gs hyperfunction in platelets and is a risk factor for bleeding.
    Freson K; Hoylaerts MF; Jaeken J; Eyssen M; Arnout J; Vermylen J; Van Geet C
    Thromb Haemost; 2001 Sep; 86(3):733-8. PubMed ID: 11583302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic imprinting and dermatological disease.
    Millington GW
    Clin Exp Dermatol; 2006 Sep; 31(5):681-8. PubMed ID: 16901310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of genomic imprinting of Gs alpha gene.
    Weinstein LS; Yu S; Liu J
    Methods Enzymol; 2002; 344():369-83. PubMed ID: 11771397
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue-specific expression of antisense and sense transcripts at the imprinted Gnas locus.
    Li T; Vu TH; Zeng ZL; Nguyen BT; Hayward BE; Bonthron DT; Hu JF; Hoffman AR
    Genomics; 2000 Nov; 69(3):295-304. PubMed ID: 11056047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imprints of disease at GNAS1.
    Lalande M
    J Clin Invest; 2001 Apr; 107(7):793-4. PubMed ID: 11285295
    [No Abstract]   [Full Text] [Related]  

  • 16. Genomic imprinting and kinship: how good is the evidence?
    Haig D
    Annu Rev Genet; 2004; 38():553-85. PubMed ID: 15568986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatment.
    Picard C; Silvy M; Gerard C; Buffat C; Lavaque E; Figarella-Branger D; Dufour H; Gabert J; Beckers A; Brue T; Enjalbert A; Barlier A
    Int J Cancer; 2007 Sep; 121(6):1245-52. PubMed ID: 17514647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model of albright hereditary osteodystrophy generated by targeted disruption of exon 1 of the Gnas gene.
    Germain-Lee EL; Schwindinger W; Crane JL; Zewdu R; Zweifel LS; Wand G; Huso DL; Saji M; Ringel MD; Levine MA
    Endocrinology; 2005 Nov; 146(11):4697-709. PubMed ID: 16099856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Practice guidelines review: Pseudohypoparathyroidism].
    Fukumoto S
    Nihon Naika Gakkai Zasshi; 2002 Apr; 91(4):1257-70. PubMed ID: 12056025
    [No Abstract]   [Full Text] [Related]  

  • 20. Minireview: GNAS: normal and abnormal functions.
    Weinstein LS; Liu J; Sakamoto A; Xie T; Chen M
    Endocrinology; 2004 Dec; 145(12):5459-64. PubMed ID: 15331575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.